Elevated platelet-free calcium in uraemia

British Journal of Haematology
A MoosaS MacNeil

Abstract

Bleeding complications in uraemia are not uncommon. The pathogenesis of haemorrhage in uraemia is still a matter of controversy and the pattern of bleeding suggests a defect of primary haemostasis. Platelet aggregation and biochemistry, including calcium levels, have been studied; however, the results are controversial. We have examined platelet aggregation, platelet-free calcium and calmodulin in platelet-rich plasma because of the significant role of calcium and calmodulin in regulating platelet and other cells' functions. Platelet aggregation in uraemic subjects was similar to that of controls. Platelet basal free cytosolic calcium and platelet calcium in response to 10 microM Ca++ ionophore A23187 in eight subjects with uraemia were 117 +/- 33 nM and 2025 +/- 398 nM (mean +/- SEM) respectively. By contrast in seven matched healthy controls basal calcium and ionophore-stimulated calcium values were 47 +/- 14 nM and 1354 +/- 414 nM, significantly less than in the patients with uraemia (P less than 0.05). The sensitivity of uraemic platelets to A23187 was similar to that of controls. Calmodulin activity in platelet-rich plasma of 12 subjects with uraemia showed no significant difference from that of controls [1.86 +/- 0.29 mic...Continue Reading

References

Apr 23, 1977·British Medical Journal·Z M RuggeriP M Mannucci
Jul 30, 1988·Lancet·A MoosaC B Brown
Dec 1, 1988·The American Journal of Medicine·H R GralnickL Pierce
Dec 1, 1987·The Biochemical Journal·P H Cobbold, T J Rink
Aug 1, 1988·Clinical Science·S M BarrP C Rubin
Nov 1, 1985·The American Journal of Medicine·G Di MinnoS Murphy
Jun 1, 1985·Thrombosis Research·T W MeadeM J Seghatchian
Jul 9, 1966·Lancet·P A CastaldiJ H Stewart
Oct 27, 1972·Annals of the New York Academy of Sciences·S F Rabiner
Jul 1, 1973·Archives of Surgery·A D Katz, L Kaplan
Jan 1, 1972·Scandinavian Journal of Haematology·H S Ballard, A J Marcus
May 14, 1983·Lancet·M WinterJ S Cameron
Feb 18, 1984·Lancet·C LeithnerW Woloszczuk
Apr 1, 1981·The Journal of Clinical Investigation·E BoginI Harary
Oct 1, 1982·European Journal of Clinical Investigation·J Vlachoyannis, W Schoeppe
Mar 1, 1983·The Journal of Clinical Investigation·G RemuzziC Patrono

❮ Previous
Next ❯

Citations

Jun 15, 2006·Wiener klinische Wochenschrift·Walter H Hörl
Oct 31, 2002·Clinical Physiology and Functional Imaging·A M KoortsM Viljoen
Jul 20, 1999·Kidney International·L SoldatiG Vezzoli
Jan 1, 1991·Clinical and Experimental Hypertension. Part A, Theory and Practice·G BañosJ Herrera-Acosta
May 1, 1993·Clinical and Experimental Hypertension : CHE·J M KrzesinskiG Rorive
Apr 1, 1997·Kidney International·A LindnerS Ringoir
Aug 12, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Stacey Dineen RodenbeckSharon M Moe
May 5, 2021·Journal of the American Society of Nephrology : JASN·Constance C F M J BaatenHeidi Noels
Jan 1, 1996·Critical Reviews in Oncology/hematology·I Fuse
Aug 15, 1998·The American Journal of the Medical Sciences·A L Weigert, A I Schafer
Jun 1, 1995·Kidney International·Z NiS G Massry
Nov 10, 2021·Clinical Journal of the American Society of Nephrology : CJASN·Constance C F M J BaatenHeidi Noels

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.